<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03886857</url>
  </required_header>
  <id_info>
    <org_study_id>SCS-CorE_AT</org_study_id>
    <nct_id>NCT03886857</nct_id>
  </id_info>
  <brief_title>Segmental Mechanisms of Transcutaneous Spinal Cord Stimulation for Spasticity Control</brief_title>
  <acronym>SCS_CorE_AT</acronym>
  <official_title>Carry-over Effects of Transcutaneous Spinal Cord Stimulation for Spasticity Control on Inhibitory Circuits of the Spinal Cord: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Lackner</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Otto Wagner Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the pilot study is to gain first insights into the interaction of transcutaneous&#xD;
      spinal cord stimulation with the altered activity of intraspinal circuits associated with&#xD;
      spinal spasticity. The main goal is to evaluate the validity of the chosen measures and to&#xD;
      generate a data base for statistical planning of a subsequent clinical study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>H_max/M_max</measure>
    <time_frame>2 hours post-intervention</time_frame>
    <description>Ratio of the maximum H reflex and the maximum M wave</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous spinal cord stimulation</intervention_name>
    <description>noninvasive electrical stimulation of the human lumbar spinal cord</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        written informed consent prior to participation&#xD;
&#xD;
        for participants with intact CNS:&#xD;
&#xD;
        • no previous neurological or musculoskeletal disorders&#xD;
&#xD;
        for participants with spinal cord injury:&#xD;
&#xD;
          -  Spinal cord injury due to trauma&#xD;
&#xD;
          -  ≥ 12 months post-spinal cord injury&#xD;
&#xD;
          -  complete or incomplete spinal cord injury classified as grade C or D on the American&#xD;
             Spinal Injury Association Impairment Scale (AIS)&#xD;
&#xD;
          -  neurological level of spinal cord injury: C3-T10&#xD;
&#xD;
          -  preserved tendon and cutaneo-muscular reflexes in the lower limbs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  other neuromuscular diseases, e.g., amyotrophic lateral sclerosis (ALS), Parkinson's&#xD;
             disease, Guillain-Barré syndrome, muscular dystrophy&#xD;
&#xD;
          -  active implants (e.g., cardiac pacemaker, drug pump)&#xD;
&#xD;
          -  passive implants at vertebral level T10 or caudal (e.g., metal screws/plates for&#xD;
             surgical stabilization of spinal fractures)&#xD;
&#xD;
          -  active infections or diseases, pressure sores&#xD;
&#xD;
          -  dermatological issues at the stimulation site&#xD;
&#xD;
          -  malignant diseases&#xD;
&#xD;
          -  heart insufficiency (NYHA III-IV)&#xD;
&#xD;
          -  potential pregnancy (pregnancy test to be conducted in women of child bearing age&#xD;
             before application of transcutaneous spinal cord stimulation)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ursula Hofstoetter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ursula Hofstoetter, PhD</last_name>
    <phone>+43 1 40400</phone>
    <phone_ext>19720</phone_ext>
    <email>ursula.hofstoetter@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Otto Wagner Hospital</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Lackner, Prof., MD</last_name>
      <phone>+43 91060</phone>
      <phone_ext>20708</phone_ext>
      <email>peter.lackner@wienkav.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 18, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <last_update_submitted>July 2, 2019</last_update_submitted>
  <last_update_submitted_qc>July 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Otto Wagner Hospital</investigator_affiliation>
    <investigator_full_name>Peter Lackner</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

